Additionally, patients should be observed for signs and symptoms of megaloblastic anemia, such as fatigue, pallor, and anorexia
implant and catheters coating that allows preventing implant-and catheter-associated infections (Veiga and Schneider, 2013)
This product is supplied exclusively to support laboratory-based research activities and is not intended for diagnostic, therapeutic, or clinical use
Fifth, and perhaps most practically, the shutdown has reminded everyone that grey-market purchases require a different mindset than buying from established pharmacies
Quick Reference: Injection site reactions: 15-25% (mild, resolve in 2-24 hours) Nausea: 5-10% (transient, first week) Dizziness: 3-7% (occasional, brief) Serious events: Zero documented in 100+ animal studies Typical dose: 250-500 mcg/day SubQ